Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 2,699 | 2,625 | 2,994 | 3,303 | 4,398 |
| Operating Income | -2,699 | -2,625 | -2,994 | -3,303 | -4,398 |
| Interest Expense | 207 | 276 | 125 | 0 | 0 |
| Other Income | 6 | 179 | 8 | 8 | 9 |
| Pre-tax Income | -2,900 | -2,722 | -3,112 | -3,295 | -4,390 |
| Net Income Continuous | -2,900 | -2,722 | -3,112 | -3,295 | -4,390 |
| Net Income | $-2,900 | $-2,722 | $-3,112 | $-3,295 | $-4,390 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-2,528 | $-2,454 | $-2,823 | $-3,128 | $-4,228 |